SNCA and Parkinson disease: Regardless, paraquat has been successfully used for animal models of PD, replicating important hallmarks of the disease such as increased α-synuclein levels and α-synuclein aggregations in SNpc neurons, leading to dopaminergic neuron loss and movement impairment (Cristóvão et al., 2020).